Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

BACKGROUND: In this retrospective analysis, we explored the prognostic and predictive value of the systemic immune-inflammation index (SII), based on lymphocyte, neutrophil, and platelet counts, at baseline and changes at week 6 during first-line sunitinib in patients with metastatic renal cell canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lolli, Cristian, Basso, Umberto, Derosa, Lisa, Scarpi, Emanuela, Sava, Teodoro, Santoni, Matteo, Crabb, Simon J., Massari, Francesco, Aieta, Michele, Conteduca, Vincenza, Maruzzo, Marco, La Russa, Francesca, Wheater, Matthew, Berardi, Rossana, Galli, Luca, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342364/
https://www.ncbi.nlm.nih.gov/pubmed/27409344
http://dx.doi.org/10.18632/oncotarget.10515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342364/
https://www.ncbi.nlm.nih.gov/pubmed/27409344
http://dx.doi.org/10.18632/oncotarget.10515

Ejemplares similares